KC-tested experimental Covid-19 vaccine moving to Warp Speed after positive study results

Inovio Pharmaceuticals Inc. announced positive results from early-stage testing of its experimental Covid-19 vaccine Tuesday and said it has been selected to participate in the federal government’s “Operation Warp Speed” program that is seeking to have a vaccine available by year’s end.

The Pennsylvania-based biotech company (Nasdaq: INO) said 94% of the phase I trial participants demonstrated overall immune responses at Week 6 after two doses of vaccine candidate INO-4800, according to a preliminary…

[

Search All New Homes For Sale

Source: Homes and Lifestyle